CytoSorbents Corporation (CTSO)

[biotech48]

This is my Unicorn scenario that doesn't dilute. HemoDefend is quickly approved by the FDA and EU and sales are huge, also a year later after both REMOVE and REFRESH are approved sales are triples worldwide. Share price rises to $60 per share and the 32 million shares are split 3/1 to give everyone 3 shares worth $20 each for the one they hold now. No dilution.